HEALTHCARE ASSOCIATED INFECTION PREVENTION
RESEARCHER PROFILE
Professor Philip Russo (Filmed June 2024)
Professor of Nursing
Director of Research, Nursing & Midwifery, Monash University &
Director of Nursing Research, Cabrini Health, Melbourne, Australia
Professor Russo is Director of Research, Nursing and Midwifery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria, Australia and Director of Nursing Research, Cabrini Health.
Professor Russo is an internationally regarded expert in healthcare associated infection prevention, and led the recently completed the Australian National Healthcare Associated Infection Point Prevalence Survey, the first in Australia for 34 years. He is also Past President of the Australasian College for Infection Prevention and Control (ACIPC), the peak body for Infection Prevention and Control professionals in the Australasian region.
Aside from his role at ACIPC, other leadership and engagement activities include; former Deputy Chair of the Infection Control Expert Group (COVID-19), a member of the National COVID-19 Clinical Evidence Taskforce Steering Committee, the National Health and Medical Research Council Infection Control Guidelines Advisory Committee, and the Healthcare Associated Infection Advisory Committee for the Australian Commission on Safety and Quality in Health Care.
Professor Russo is the recipient of a National Health and Medical Research Early Career Fellowship and has attracted research funding from government, industry, philanthropic and academic sources. He has presented at both national and international conferences, authored over 100 peer reviewed articles and several book chapters.
-
Computer science approach to detecting dementia
Watch Xinyi Wang, a researcher at the Wicking Dementia Research and Education Centre, University of Tasmania talk on identifying new approaches to detecting dementia.
-
World-first clinical trial improves patient outcomes for kidney transplants (2023)
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Around one in three people who receive a kidney transplant suffer delayed graft function, which means the transplant doesn’t work immediately and they require dialysis.
The lead-author of the study, was Royal Adelaide Hospital Nephrologist and University of Adelaide researcher, Dr Michael Collins.
-
Indigenous Australian health and ear disease
Professor Kelvin Kong feels incredibly fortunate to lead a fulfilling life surrounded by his loved ones. With a demonstrated history of service in the health industry, he brings a wealth of expertise across various sectors including clinical research, medical education, surgery, paediatrics, health policy, and Indigenous education. Kelvin started his university, residing at New College in 1992, which brings him fond memories. Graduating from medicine from the University of NSW, Kelvin continued his studies and became a fellow of the Royal Australasian College of Surgeons (RACS) and Australian Society of Otolaryngology, head & neck Society (ASOHNS).
